Filing Flows › Comparisons › NVS vs ABT
Novartis AG vs Abbott Laboratories: NVS and ABT compared
Novartis AG is the larger company: $14.5B of revenue in its latest quarter (Q3 2026) against $13.0B for Abbott Laboratories (Q3 2026). Abbott Laboratories is growing faster (+14% against +4% a year earlier). Novartis AG is more profitable, with an operating margin of 12.7% against 10.4%.
Where the money goes: NVS and ABT
Novartis AG (NVS) · Q3 2026
Novartis AG, Q3 2026: revenue $14.5B (+4% year over year), operating margin 12.7%, net earnings $1.2B, operating cash flow $5.5B. The chart follows the revenue to costs, profit and cash.
Abbott Laboratories (ABT) · Q3 2026
Abbott Laboratories, Q3 2026: revenue $13.0B (+14% year over year), operating margin 10.4%, net earnings $920M, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.
| Novartis AG (NVS) | Abbott Laboratories (ABT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $14.5B | $13.0B |
| Revenue growth, Y/Y | +4% | +14% |
| Operating margin | 12.7% | 10.4% |
| Net earnings | $1.2B | $920M |
| Net margin | 8.2% | 7.1% |
| Operating cash flow | $5.5B | $1.7B |
| Free cash flow | — | $1.2B |
| Market value | — | $197.4B |
| P/E | — | 42.4× |
| Analysts’ mean target | — | $118.52 |
Questions
Which is bigger, Novartis AG or Abbott Laboratories?
Novartis AG is the larger company: $14.5B of revenue in its latest quarter (Q3 2026) against $13.0B for Abbott Laboratories (Q3 2026).
Is Novartis AG or Abbott Laboratories growing faster?
Abbott Laboratories is growing faster (+14% against +4% a year earlier).
Which is more profitable, Novartis AG or Abbott Laboratories?
Novartis AG is more profitable, with an operating margin of 12.7% against 10.4%.
More: Novartis AG earnings · how Novartis AG makes money · Abbott Laboratories earnings · how Abbott Laboratories makes money
From the companies' latest 10-Q, 10-K or earnings release (6-K filed Oct 27, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.